SCHEMBL12103403

SCHEMBL12103403

C[C@H](CC(=O)O)C1CCN(C)CC1

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CACNA2D1 P54289 4/20 0.40
CACNA1B Q00975 4/20 0.40
CACNB1 Q02641 4/20 0.40
CACNA1C Q13936 4/20 0.40
REN P00797 1/20 0.39
ACE P12821 1/20 0.39
ALDH1A1 P00352 3/20 0.36
KDM4E B2RXH2 2/20 0.36
LMNA P02545 1/20 0.36
MAPT P10636 1/20 0.36
ALOX15 P16050 1/20 0.36
TSHR P16473 1/20 0.36
HTR1A P08908 1/20 0.36
CPN1 P15169 1/20 0.36
CPB2 Q96IY4 1/20 0.36
GNAI3 P08754 2/20 0.35
GNAO1 P09471 2/20 0.35
GNAI1 P63096 2/20 0.35
KDM4C Q9H3R0 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12617369 1.00 CACNA2D1 (0.40) CACNA2D1CACNA1BCACNB1CACNA1CREN
SCHEMBL31467987 0.85 NCF1 (0.38) CACNA2D1CACNA1BCACNB1CACNA1CHTR1A
SCHEMBL5967438 0.83
SCHEMBL1295911 0.83 CPN1 (0.41) RENACEALDH1A1CPN1CPB2
SCHEMBL11310195 0.81 CPN1 (0.44) RENACEMAPTCPN1CPB2
SCHEMBL6559712 0.78 ALDH1A1 (0.37) CACNA2D1CACNA1CRENACEALDH1A1
SCHEMBL1208925 0.78 ALDH1A1 (0.55) RENACEALDH1A1
SCHEMBL8651989 0.78 ALDH1A1 (0.55) RENACEALDH1A1
SCHEMBL6808670 0.78 ALDH1A1 (0.55) RENACEALDH1A1
SCHEMBL8967209 0.75 NCF1 (0.38) CACNA2D1CACNA1BCACNB1CACNA1CHTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110269734-A1 PIPERIDINYL GPCR AGONISTS PROSIDION LIMITED (GB) 2011-11-03 US disclosed
US-20110230507-A1 Piperidine GPCR Agonists PROSIDION LIMITED (GB) 2011-09-22 US disclosed
US-20110195994-A1 Piperidinyl GPCR Agonists PROSIDION LIMITED (GB) 2011-08-11 US disclosed
US-20100286112-A1 COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS PROSIDION LIMITED (GB) 2010-11-11 US disclosed
US-20100105732-A1 PIPERIDINE GPCR AGONISTS PROSIDION LIMITED (GB) 2010-04-29 US disclosed
US-20100048625-A1 PIPERIDINE GPCR AGONISTS PROSIDION LIMITED (GB) 2010-02-25 US disclosed
US-20100048632-A1 Piperidine GPCR Agonists PROSIDION LIMITED (GB) 2010-02-25 US disclosed
US-20100048631-A1 Piperidine GPCR Agonists PROSIDION LIMITED (GB) 2010-02-25 US disclosed
US-20100022591-A1 PIPERIDINE GPCR AGONISTS PROSIDION LIMITED (GB) 2010-01-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100022591-A1 PIPERIDINE GPCR AGONISTS GPR119, GPR27, GLP1R CACNA2D1 1900/4885CACNA1B 976/4885CACNB1 1719/4885
US-20110195994-A1 Piperidinyl GPCR Agonists GPR119, GPR27, GLP1R CACNA2D1 2431/4885CACNA1B 1174/4885CACNB1 1886/4885
US-20100048632-A1 Piperidine GPCR Agonists GPR119, GPR27, GLP1R CACNA2D1 1900/4885CACNA1B 976/4885CACNB1 1719/4885
US-20110269734-A1 PIPERIDINYL GPCR AGONISTS GPR119, GPR27, GLP1R CACNA2D1 2431/4885CACNA1B 1174/4885CACNB1 1886/4885
US-20100286112-A1 COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS GPR119, DPP4, DPP9 CACNA2D1 2882/4885CACNA1B 2038/4885CACNB1 2872/4885
US-20100105732-A1 PIPERIDINE GPCR AGONISTS GPR119, GPR27, GLP1R CACNA2D1 1900/4885CACNA1B 976/4885CACNB1 1719/4885
US-20110230507-A1 Piperidine GPCR Agonists GPR119, GPR27, GLP1R CACNA2D1 1830/4885CACNA1B 983/4885CACNB1 1670/4885
US-20100048631-A1 Piperidine GPCR Agonists GPR119, GPR27, GLP1R CACNA2D1 1900/4885CACNA1B 976/4885CACNB1 1719/4885
US-20100048625-A1 PIPERIDINE GPCR AGONISTS GPR119, GPR27, GLP1R CACNA2D1 1900/4885CACNA1B 976/4885CACNB1 1719/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.